Dechra Launches Domidine Equine Sedative in the US Quick Takeaways: Why It Matters? Dechra’s US launch of Domidine (detomidine) adds a generic, cost‑effective alpha‑2 agonist to the equine sedation market, giving veterina...
Quick Takeaways: Why It Matters? Boehringer Ingelheim’s purchase of Evax gives it a promising new way to treat common horse allergies with longer‑lasting vaccines instead of short‑term symptom relief, which could mean fewer vet visits and better outcomes for owners. If the approach works a...
Quick Takeaways: Why It Matters? With 138 horses across eight practices showing significantly better outcomes and nearly triple the odds of returning to prior performance, the data should help veterinarians justify using equicenta CTM as a convenient, regenerative alternative to harvesting...
Quick Takeaways: Why It Matters? The launch should help Zomedica make PulseVet easier to use in everyday practice by improving patient and staff comfort, potentially reducing anxiety-driven resistance and making clinics more willing to adopt or keep using shock wave therapy for equine and ...
Quick Takeaways: Why It Matters? The EUA makes ivermectin liquid a short-term, horse-only screwworm prophylaxis tool, adding another regulated option to the NWS armamentarium and slightly strengthening biosecurity for foals and wounded horses, but because protection lasts only 24 hours and...
